United States· US:56062-306_54331f8b-54e5-4560-8365-856b900d8b94

clearlax

A medicinal product containing polyethylene glycol 3350, registered in United States by Publix Super Markets Inc.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedclearlaxATC—REGISTER NO.US:56062-306_54331f8b…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
POLYETHYLENE GLYCOL 3350
Manufacturer
Publix Super Markets Inc
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    56062-306-02
  • ndc11
    56062-306-03
  • ndc11
    5606230602
    238 g in 1 BOTTLE (56062-306-02)
  • ndc11
    5606230603
    510 g in 1 BOTTLE (56062-306-03)
  • ndc11
    5606230604
    850 g in 1 BOTTLE (56062-306-04)
  • ndc11
    56062-306-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Polyethylene glycol 3350 in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All polyethylene glycol 3350 products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Transisoft
  • Germany · Transisoft
  • France · Transipeg, Transipeglib
  • United Kingdom (Northern Ireland) · Transisoft
  • Ireland · Transisoft
  • Italy · Transisoft

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6dcde18c-4d4b-440c-975a-8b28a508f339
GET /v1/drugs/6dcde18c-4d4b-440c-975a-8b28a508f339?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "17",
  "substance": "POLYETHYLENE GLYCOL 3350",
  "productndc": "56062-306",
  "dosage_form": "POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/17g",
  "application_number": "ANDA090685",
  "marketing_category": "ANDA"
}

See everything about polyethylene glycol 3350.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.